ClinicalTrials.Veeva

Menu

Efficacy of Acupuncture and Bee Venom Acupuncture on Patients With Idiopathic Parkinson's Disease

K

Kyung Hee University

Status

Completed

Conditions

Idiopathic Parkinson's Disease

Treatments

Device: sham acupuncture and normal saline injections
Device: acupuncture and bee venom acupuncture point injection

Study type

Interventional

Funder types

Other

Identifiers

NCT01970813
NRF-2011-0021389

Details and patient eligibility

About

The aim of this study is to evaluate the efficacy of acupuncture and bee venom acupuncture (BVA) for idiopathic Parkinson's disease (IPD) through a sham-controlled trial and investigate whether there is sustainability of treatments effects by follow-up assessments after the end of the treatment.

Full description

A total of 90 patients with idiopathic Parkinson's disease (IPD) who have been on a stable dose of anti-parkinsonian medication for at least one month with two or more symptoms among tremor, rigidity, postural instability, and bradykinesia will be included in this study. Participants will be randomly assigned to the study, the control, or the waiting group (2:2:1).

Initial assessment will be performed with the Unified Parkinson's Disease Rating Scale (UPDRS) parts II and III, the Parkinson's Disease Quality of Life Questionnaire (PDQL), the Beck Depression Inventory (BDI), and evaluation of the 20-m walking time and the steps to walk 20-m, as well as postural instability.

Acupuncture and BVA treatments will then be performed on the study group, and sham acupuncture and normal saline injections will be performed on the control group twice a week for 12 weeks. The waiting group does not receive any added treatment during the 12 weeks.

The initial assessment will be repeated after 12 weeks in all groups. In the study and the control groups, an additional assessment will be repeated after 16 and 20 weeks.

Enrollment

74 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with IPD who have been on a stable dose of anti-parkinsonian medication for at least one month.
  • Hoehn & Yahr scale I-IV
  • More than one point in two or more items (tremor, rigidity, postural instability, and bradykinesia) in the UPDRS Part III, etc.

Exclusion criteria

  • Severe psychiatric or organic brain disorders other than PD, previous or current
  • Secondary Parkinsonism due to cerebrovascular disease, tumor, infection, etc.
  • Atypical Parkinsonian or Parkinson plus syndrome

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

74 participants in 3 patient groups

Study group
Active Comparator group
Description:
acupuncture and bee venom acupuncture point injection
Treatment:
Device: acupuncture and bee venom acupuncture point injection
Control group
Sham Comparator group
Description:
sham acupuncture and normal saline injections
Treatment:
Device: sham acupuncture and normal saline injections
Waiting group
No Intervention group
Description:
no additional intervention

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems